PD-1-KO-T cell injection / Chengdu MedGenCell - LARVOL DELTA

PD-1 Knockout Engineered T Cells for Metastatic Non-small Cell Lung Cancer (clinicaltrials.gov) - P1; N=12; Completed; Sponsor: Sichuan University; Active, not recruiting ➔ Completed

Clinical • IO Biomarker • Trial completion • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • ALK • IL10 • IL6 • PD-1 • TNFA

PD-1 Knockout Engineered T Cells for Metastatic Non-small Cell Lung Cancer (clinicaltrials.gov) - P1; N=12; Active, not recruiting; Sponsor: Sichuan University; Trial completion date: Jun 2019 ➔ Jan 2020; Trial primary completion date: Jun 2019 ➔ Aug 2018

Clinical • Trial completion date • Trial primary completion date

PD-1 Knockout Engineered T Cells for Metastatic Non-small Cell Lung Cancer (clinicaltrials.gov) - P1; N=12; Active, not recruiting; Sponsor: Sichuan University; Trial completion date: Dec 2018 ➔ Jun 2019; Trial primary completion date: Dec 2018 ➔ Jun 2019

Clinical • Trial completion date • Trial primary completion date